Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Kymera Therapeutics, Inc.(KYMR) | 2,847,541 | 2,847,541 | 0 | $326.53M | $318.33M | 50.43% | -$8.20M |
| Disc Medicine, Inc.(IRON) | 1,513,875 | 1,384,025 | -129,850 | $110.72M | $90.60M | 14.35% | -$20.13M |
| Obsidian Therapeutics, Inc. | 0 | 4,503,149 | +4,503,149 | $0 | $61.83M | 9.80% | +$61.83M |
| Kailera Therapeutics, Inc. | 5,171,282 | 5,171,282 | 0 | $113.92M | $59.06M | 9.36% | -$54.87M |
| Dyne Therapeutics, Inc.(DYN) | 6,800,099 | 3,440,720 | -3,359,379 | $151.03M | $55.43M | 8.78% | -$95.60M |
| Q32 Bio, Inc. | 2,717,106 | 2,717,106 | 0 | $34.62M | $22.47M | 3.56% | -$12.15M |
| Sionna Therapeutics, Inc. | 2,995,602 | 2,995,602 | 0 | $131.78M | $15.76M | 2.50% | -$116.02M |
| Korro Bio, Inc. | 962,884 | 773,260 | -189,624 | $12.69M | $7.66M | 1.21% | -$5.03M |
| Odyssey Therapeutics, Inc. | 0 | 2,692 | +2,692 | $0 | $59.8K | 0.01% | +$59.8K |